| RS2542075835 |
POLE
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2542089179 |
WDR72
|
Health Risk |
Pathogenic |
Amelogenesis imperfecta, Amelogenesis imperfecta |
| RS2542089584 |
MYO1E
|
Health Risk |
Pathogenic |
— |
| RS2542089684 |
POLE
|
Health Risk |
Pathogenic |
— |
| RS2542090484 |
POLE
|
Health Risk |
Pathogenic |
— |
| RS2542091859 |
RB1
|
Health Risk |
Likely pathogenic |
Retinoblastoma, Retinoblastoma |
| RS2542091863 |
RB1
|
Health Risk |
Likely pathogenic |
Retinoblastoma, Retinoblastoma |
| RS2542092554 |
SGCG
|
Health Risk |
Pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2C, Autosomal recessive limb-girdle muscular dystrophy type 2C |
| RS2542093245 |
RB1
|
Health Risk |
Pathogenic |
Retinoblastoma, Retinoblastoma |
| RS2542093257 |
RB1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2542093262 |
RB1
|
Health Risk |
Pathogenic |
Retinoblastoma, Retinoblastoma |
| RS2542093276 |
RB1
|
Health Risk |
Pathogenic |
Retinoblastoma, Retinoblastoma |
| RS2542093316 |
RB1
|
Health Risk |
Pathogenic |
Retinoblastoma, Neoplasm |
| RS2542093570 |
RB1
|
Health Risk |
Pathogenic |
Retinoblastoma, Retinoblastoma |
| RS2542093585 |
RB1
|
Health Risk |
Pathogenic |
Retinoblastoma, Retinoblastoma |
| RS2542093681 |
RB1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2542094345 |
RB1
|
Health Risk |
Pathogenic |
Retinoblastoma, Retinoblastoma |
| RS2542094349 |
RB1
|
Health Risk |
Pathogenic |
Retinoblastoma, Retinoblastoma |
| RS2542094356 |
RB1
|
Health Risk |
Pathogenic |
Retinoblastoma, Retinoblastoma |
| RS2542094478 |
RB1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2542094495 |
RB1
|
Health Risk |
Pathogenic |
Retinoblastoma, Retinoblastoma |
| RS2542094556 |
RB1
|
Health Risk |
Pathogenic |
Retinoblastoma, Retinoblastoma |
| RS2542096421 |
POLE
|
Health Risk |
Pathogenic |
— |
| RS2542096701 |
POLE
|
Health Risk |
Pathogenic |
Colorectal cancer, susceptibility to |
| RS2542099867 |
RB1
|
Health Risk |
Pathogenic |
Retinoblastoma, Retinoblastoma |
| RS2542099907 |
RB1
|
Health Risk |
Pathogenic |
Retinoblastoma, Retinoblastoma |
| RS2542099953 |
RB1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2542099970 |
RB1
|
Health Risk |
Pathogenic |
Retinoblastoma, Retinoblastoma |
| RS2542100048 |
RB1
|
Health Risk |
Pathogenic |
Retinoblastoma, Retinoblastoma |
| RS2542100256 |
RB1
|
Health Risk |
Pathogenic |
Retinoblastoma, Retinoblastoma |
| RS2542100268 |
RB1
|
Health Risk |
Pathogenic |
Retinoblastoma, Retinoblastoma |
| RS2542100326 |
RB1
|
Health Risk |
Pathogenic |
Retinoblastoma, Retinoblastoma |
| RS2542100363 |
RB1
|
Health Risk |
Pathogenic |
Retinoblastoma, Retinoblastoma |
| RS2542100494 |
RB1
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinoblastoma, Hereditary cancer-predisposing syndrome |
| RS2542101470 |
POLE
|
Health Risk |
Pathogenic |
— |
| RS2542101554 |
POLE
|
Health Risk |
Pathogenic |
— |
| RS2542101674 |
POLE
|
Health Risk |
Pathogenic |
— |
| RS2542103069 |
SGCG
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2C, Autosomal recessive limb-girdle muscular dystrophy type 2C |
| RS2542103135 |
SGCG
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2C, Autosomal recessive limb-girdle muscular dystrophy type 2C |
| RS2542103356 |
POLE
|
Health Risk |
Likely pathogenic |
— |
| RS2542103387 |
SGCG
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2C, Autosomal recessive limb-girdle muscular dystrophy type 2C |
| RS2542104080 |
POLR3B
|
Health Risk |
Likely pathogenic |
— |
| RS2542104965 |
POLE
|
Health Risk |
Pathogenic |
— |
| RS2542109823 |
WDR72
|
Health Risk |
Likely pathogenic |
Amelogenesis imperfecta hypomaturation type 2A3, Amelogenesis imperfecta hypomaturation type 2A3 |
| RS2542110126 |
POLR3B
|
Health Risk |
Likely pathogenic |
— |
| RS2542118910 |
POLR3B
|
Health Risk |
Pathogenic |
— |
| RS2542127860 |
POLE
|
Health Risk |
Pathogenic |
— |
| RS2542128153 |
POLE
|
Health Risk |
Pathogenic |
— |
| RS2542133713 |
POLE
|
Health Risk |
Pathogenic |
— |
| RS2542134020 |
POLE
|
Health Risk |
Pathogenic |
— |
| RS2542134326 |
POLE
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2542134730 |
SACS
|
Health Risk |
Likely pathogenic |
Charlevoix-Saguenay spastic ataxia, Charlevoix-Saguenay spastic ataxia |
| RS2542134839 |
POLE
|
Health Risk |
Pathogenic |
— |
| RS2542135635 |
POLE
|
Health Risk |
Pathogenic |
— |
| RS2542136084 |
SACS
|
Health Risk |
Likely pathogenic |
Charlevoix-Saguenay spastic ataxia, Charlevoix-Saguenay spastic ataxia |
| RS2542137178 |
SACS
|
Health Risk |
Pathogenic |
Spastic paraplegia, Spastic paraplegia |
| RS2542138113 |
SACS
|
Health Risk |
Likely pathogenic |
Charlevoix-Saguenay spastic ataxia, Charlevoix-Saguenay spastic ataxia |
| RS2542138331 |
SACS
|
Health Risk |
Pathogenic |
Spastic paraplegia, Spastic paraplegia |
| RS2542138352 |
SACS
|
Health Risk |
Pathogenic |
Spastic paraplegia, Spastic paraplegia |
| RS2542139339 |
SACS
|
Health Risk |
Likely pathogenic |
Charlevoix-Saguenay spastic ataxia, Charlevoix-Saguenay spastic ataxia |
| RS2542139382 |
SACS
|
Health Risk |
Likely pathogenic |
Charlevoix-Saguenay spastic ataxia, Autosomal recessive spastic ataxia |
| RS2542139536 |
POLE
|
Health Risk |
Pathogenic |
— |
| RS2542140157 |
CEP164
|
Health Risk |
Pathogenic |
Nephronophthisis 15, Nephronophthisis 15 |
| RS2542140941 |
POLE
|
Health Risk |
Pathogenic |
— |
| RS2542141009 |
POLE
|
Health Risk |
Pathogenic |
— |
| RS2542141517 |
SACS
|
Health Risk |
Pathogenic/Likely pathogenic |
Spastic paraplegia, Spastic paraplegia |
| RS2542143632 |
SACS
|
Health Risk |
Likely pathogenic |
Charlevoix-Saguenay spastic ataxia, Charlevoix-Saguenay spastic ataxia |
| RS2542145071 |
POLE
|
Health Risk |
Pathogenic |
— |
| RS2542145750 |
POLE
|
Health Risk |
Pathogenic |
— |
| RS2542145946 |
SACS
|
Health Risk |
Pathogenic |
Spastic paraplegia, Spastic paraplegia |
| RS2542146046 |
POLE
|
Health Risk |
Pathogenic |
— |
| RS2542146457 |
POLE
|
Health Risk |
Pathogenic |
— |
| RS2542146685 |
SACS
|
Health Risk |
Likely pathogenic |
Charlevoix-Saguenay spastic ataxia, Charlevoix-Saguenay spastic ataxia |
| RS2542147207 |
SACS
|
Health Risk |
Pathogenic/Likely pathogenic |
Charlevoix-Saguenay spastic ataxia, Spastic paraplegia |
| RS2542147593 |
POLE
|
Health Risk |
Pathogenic |
— |
| RS2542149542 |
SACS
|
Health Risk |
Likely pathogenic |
Charlevoix-Saguenay spastic ataxia, Charlevoix-Saguenay spastic ataxia |
| RS2542150460 |
SACS
|
Health Risk |
Pathogenic |
Spastic paraplegia, Spastic paraplegia |
| RS2542150696 |
SACS
|
Health Risk |
Pathogenic |
Spastic paraplegia, Spastic paraplegia |
| RS2542151101 |
SACS
|
Health Risk |
Likely pathogenic |
Charlevoix-Saguenay spastic ataxia, Charlevoix-Saguenay spastic ataxia |
| RS2542153725 |
SACS
|
Health Risk |
Likely pathogenic |
Charlevoix-Saguenay spastic ataxia, Charlevoix-Saguenay spastic ataxia |
| RS2542153994 |
SACS
|
Health Risk |
Pathogenic |
Charlevoix-Saguenay spastic ataxia, Charlevoix-Saguenay spastic ataxia |
| RS2542154639 |
SACS
|
Health Risk |
Likely pathogenic |
Charlevoix-Saguenay spastic ataxia, Charlevoix-Saguenay spastic ataxia |
| RS2542155049 |
SACS
|
Health Risk |
Pathogenic/Likely pathogenic |
Spastic paraplegia, Spastic paraplegia |
| RS2542155609 |
SACS
|
Health Risk |
Pathogenic |
Spastic paraplegia, Spastic paraplegia |
| RS2542155892 |
RB1
|
Health Risk |
Pathogenic |
Retinoblastoma, Retinoblastoma |
| RS2542155973 |
RB1
|
Health Risk |
Pathogenic |
Retinoblastoma, Retinoblastoma |
| RS2542155979 |
RB1
|
Health Risk |
Pathogenic |
Retinoblastoma, Retinoblastoma |
| RS2542155996 |
RB1
|
Health Risk |
Pathogenic |
Retinoblastoma, Retinoblastoma |
| RS2542156044 |
SACS
|
Health Risk |
Likely pathogenic |
Charlevoix-Saguenay spastic ataxia, Charlevoix-Saguenay spastic ataxia |
| RS2542156125 |
RB1
|
Health Risk |
Pathogenic |
Retinoblastoma, Retinoblastoma |
| RS2542156233 |
RB1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Retinoblastoma |
| RS2542156330 |
RB1
|
Health Risk |
Pathogenic |
Lung adenocarcinoma, Retinoblastoma |
| RS2542157770 |
POLE
|
Health Risk |
Pathogenic |
— |
| RS2542157981 |
POLE
|
Health Risk |
Pathogenic |
— |
| RS2542157997 |
POLE
|
Health Risk |
Pathogenic |
Colorectal cancer, susceptibility to |
| RS2542158546 |
POLE
|
Health Risk |
Conflicting classifications of pathogenicity |
Colorectal cancer, susceptibility to |
| RS2542158730 |
POLE
|
Health Risk |
Pathogenic |
— |
| RS2542158927 |
SACS
|
Health Risk |
Likely pathogenic |
Charlevoix-Saguenay spastic ataxia, Charlevoix-Saguenay spastic ataxia |
| RS2542159094 |
POLE
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Colorectal cancer |
| RS2542159160 |
RB1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |